The associated higher probability of detecting an interval CRC in this small population, coupled with the large proportion of participants with a negative FIT and an unmeasurable f‐Hb concentration, indicates possibilities for risk‐stratified CRC screening. The gene discussed is GSTM1; the disease is colorectal carcinoma.